-
EP0514449
European procedure
Extract from the Register of European Patents
EP About this file: EP0514449
| EP0514449 - NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.03.1998 Database last updated on 11.04.2026 | Most recent event Tooltip | 05.10.2005 | Change: Appeal number | Applicant(s) | For all designated states THERAPEUTIQUES SUBSTITUTIVES Université Paris-Nord - CSP - LRM, Avenue J.B.Clément F-93430 Villetaneuse / FR | [1992/48] | Inventor(s) | 01 /
JOZEFOWICZ, Jacqueline 65, deuxième avenue F-60260 Lamorlaye / FR | 02 /
HARMAND, Marie-Françoise 26, rue Berruer F-33000 Bordeaux / FR | 03 /
SLAOUI, Faouzi 23, boulevard Mohammed V Meknes / MA | [1992/48] | Representative(s) | Orès, Irène, et al Cabinet ORES 36,rue de St Pétersbourg 75008 Paris / FR | [N/P] |
| Former [1992/48] | Ores, Irène, et al CABINET ORES 6, Avenue de Messine F-75008 Paris / FR | Application number, filing date | 91904092.3 | 06.02.1991 | [1992/48] | WO1991FR00092 | Priority number, date | FR19900001343 | 06.02.1990 Original published format: FR 9001343 | [1992/48] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO9112011 | Date: | 22.08.1991 | Language: | FR | [1991/19] | Type: | A1 Application with search report | No.: | EP0514449 | Date: | 25.11.1992 | Language: | FR | The application published by WIPO in one of the EPO official languages on 22.08.1991 takes the place of the publication of the European patent application. | [1992/48] | Type: | B1 Patent specification | No.: | EP0514449 | Date: | 14.05.1997 | Language: | FR | [1997/20] | Search report(s) | International search report - published on: | EP | 22.08.1991 | Classification | IPC: | A61K31/72, A61K31/735 | [1992/48] | CPC: |
C08B37/0021 (EP);
A61P35/00 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1992/48] | Title | German: | DEXTRANVERBINDUNG ALS ANTITUMORMITTEL | [1992/48] | English: | NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN | [1992/48] | French: | NOUVEL AGENT ANTITUMORAL DERIVE DU DEXTRANE | [1992/48] | Entry into regional phase | 21.07.1992 | National basic fee paid | 21.07.1992 | Designation fee(s) paid | 21.07.1992 | Examination fee paid | Examination procedure | 06.02.1990 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 23.07.1992 | Examination requested [1992/48] | 13.01.1993 | Despatch of communication of intention to grant (Approval: No) | 28.07.1993 | Despatch of a communication from the examining division (Time limit: M02) | 21.09.1993 | Reply to a communication from the examining division | 07.04.1994 | Despatch of communication that the application is refused, reason: substantive examination {1} | 09.10.1996 | Despatch of communication of intention to grant (Approval: later approval) | 14.11.1996 | Communication of intention to grant the patent | 21.01.1997 | Fee for grant paid | 21.01.1997 | Fee for publishing/printing paid | Appeal following examination | 30.05.1994 | Appeal received No. T0958/94 | 05.08.1994 | Statement of grounds filed | 19.01.1996 | Invitation to file observations in an appeal (Time limit: M02) [1996/03] | 19.03.1996 | Date of receipt of observations in an appeal [1996/12] | 30.09.1996 | Result of appeal procedure: remittal for grant | Opposition(s) | 17.02.1998 | No opposition filed within time limit [1998/19] | Fees paid | Renewal fee | 01.02.1993 | Renewal fee patent year 03 | 07.01.1994 | Renewal fee patent year 04 | 16.02.1995 | Renewal fee patent year 05 | 09.02.1996 | Renewal fee patent year 06 | 14.02.1997 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] JP53105584 | [A] Molecular Immunology, vol. 25, no. 2, 23 fvrier 1988 M.P. Carreno et al.: "The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives", pages 165-171 [A] | [A] WPI, File Supplier, AN=78-75503A, Derwent Publications Ltd, (Londres, GB) & JP-A-53105584 (MEITO SANGYO) 13 septembre 1978 [A] |